News Sentiment

XLO sentiment intelligence

Xilio Development Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 45 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 9.10 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 36

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-0.5% over one week, +9.5% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market Reaction

Balanced read

54/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction -0.5% Price digesting
Trend fit Trend inactive 9.5% over four weeks
Fair value -33.4% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 31
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 36
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
TradingView 9
Stock Titan 9
www.marketscreener.com 3
The Globe and Mail 2
dars.gov.et 2
TradingKey 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 25
Earnings 15
Analyst action 2
Regulatory and legal 1
Deals and strategy 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-45 of 45